Sign In
Buy SOPH
$5.67
-0.0900 (-1.56%)
At Close: Jul 31, 2026
SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021
03:32pm, Monday, 29'th Nov 2021 PR Newswire
Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and
SOPHiA Genetics SA (NASDAQ:SOPH) Expected to Announce Quarterly Sales of $11.33 Million
07:00am, Thursday, 25'th Nov 2021 Dakota Financial News
Wall Street brokerages expect that SOPHiA Genetics SA (NASDAQ:SOPH) will report sales of $11.33 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for SOPHiA Genetics earnings, with the lowest sales estimate coming in at $11.26 million and the highest estimate coming in at $11.40 million. The company []
-$0.34 EPS Expected for SOPHiA Genetics SA (NASDAQ:SOPH) This Quarter
06:14pm, Tuesday, 23'rd Nov 2021 Dakota Financial News
Brokerages expect SOPHiA Genetics SA (NASDAQ:SOPH) to announce earnings per share of ($0.34) for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for SOPHiA Genetics’ earnings, with the highest EPS estimate coming in at ($0.32) and the lowest estimate coming in at ($0.36). The business is scheduled to announce its next […]
SOPHiA GENETICS SA (SOPH) CEO Jurgi Camblong on Q3 2021 Results - Earnings Call Transcript
12:14pm, Sunday, 14'th Nov 2021
SOPHiA GENETICS SA (SOPH) CEO Jurgi Camblong on Q3 2021 Results - Earnings Call Transcript
SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021
04:05pm, Wednesday, 27'th Oct 2021
BOSTON and LAUSANNE, Switzerland, Oct. 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market open
SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseases
03:29pm, Tuesday, 12'th Oct 2021
BOSTON and LAUSANNE, Switzerland, Oct. 12, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven med
SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
04:05pm, Monday, 30'th Aug 2021
BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global Health
UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
12:43pm, Thursday, 26'th Aug 2021
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open
SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
09:00am, Thursday, 26'th Aug 2021
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open
Dasa expands partnership with SOPHiA GENETICS for the first decentralized cancer biomarker detection solution in Latin America
09:00am, Tuesday, 24'th Aug 2021
SÃO PAULO, Brazil and BOSTON, Aug. 24, 2021 /PRNewswire/ -- Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH)
SOPHiA Genetics set to go public at a $1.1 billion valuation
07:49am, Friday, 23'rd Jul 2021
SOPHiA Genetics SA is set up for a public debut Friday, as the Switzerland-based data-driven medicine company's initial public offering price overnight at $18 a share, which was in the middle of the e
AI-based Healthcare Data Analytics Platform Provider Sophia Genetics Makes Its Wall Street Debut: What You Need to Know
06:26am, Friday, 23'rd Jul 2021
Switzerland-based Sophia Genetics SA (NASDAQ: SOPH), a healthcare tech company, is debuting on Wall Street Friday. Here is what you should know about the company.
